Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa

Blood

Volumn 94, Issue 2, 1999, Pages 587-599

  Bednar, Bohumil ^a   Cook, Jacquelynn ^a   Holahan, Marie A ^a   Cunningham, Michael E ^a   Jumes, Patricia A ^a   Bednar, Rodney A ^a   Hartman, George D ^a   Gould, Robert J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ETHYNYL N [[1,2,3,4 TETRAHYDRO 1 OXO 7 (1 PIPERAZINYL) 2 ISOQUINOLINYL]ACETYL] BETA ALANINE; 3 ETHYNYL N [[1,2,3,4 TETRAHYDRO 1 OXO 7 (1 PIPERAZINYL) 2 ISOQUINOLINYL]ACETYL] BETA ALANINE BENZYL ESTER; 3 ETHYNYL N [[1,2,3,4 TETRAHYDRO 1 OXO 7 (1 PIPERAZINYL) 2 ISOQUINOLINYL]ACETYL] BETA ALANINE ETHYL ESTER; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; L 734217; L 739758; L 740356; L 742169; L 742942; L 762745; N [(4 METHYLPHENYL)SULFONYL] 3 [[[5,6,7,8 TETRAHYDRO 4 OXO 5 [2 (4 PIPERIDINYL)ETHYL] 4H PYRAZOLO[1,5 A][1,4]DIAZEPIN 2 YL]CARBONYL]AMINO]ALANINE; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CERCOPITHECIDAE; CHIMPANZEE; CONTROLLED STUDY; DOG; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHESUS MONKEY; SQUIRREL MONKEY; THROMBOCYTOPENIA;

EID: 0033566348     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.587     Document Type: Article

References (39)

1. Tcheng JE: Platelet glycoprotein IIb/IIIa integrin blockage: Recent clinical trials in intervention cardiology. Thromb Haemost 78:205, 1997
2. Van de Werf F: Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes. Thromb Haemost 78:210, 1997
3. Coller BS: GP IIb/IIIa antagonists: Pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 78:731, 1997
4. Muller TH, Weisenberger H, Brickl R, Narjes H, Himmelsbach F, Krause J: Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men. Circulation 96:1130, 1997
5. Cines DB: Glycoprotein IIb/IIIa antagonists: Potential induction and detection of drug-dependent antiplatelet antibodies. Am Heart J 135:8152, 1998
6. Kereiakes DJ, Essell JH, Abbottsmith CW, Broderick TM, Runyon JP: Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion. Am J Cardiol 78:1161, 1996
7. Berkowitz SD, Harrington RA, Rund MM, Tcheng JE: Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Circulation 95:809, 1997
8. The IMPACT-II investigators: Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to minimize platelet aggregation and coronary thrombosis-II. Lancet 349:1422, 1997
9. The RESTORE investigators: Effect of platelet glycoprotein IIb/IIIa blockage with tirofiban and adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96:1445, 1997
10. Catella-Lawson F, Kapoor S, Skammer W, Fitzgerald DJ, Rocca B, Tamby JF, FitzGerald GA: Chronic inhibition of platelet glycoprotein IIb/IIIa by a new oral agent: a dose-escalation study in patients with coronary artery disease (CAD). Thromb Haemost 78:393a, 1997 (abstr, suppl)
11. Rosenthal N: The blood picture in purpura. J Lab Clin Med 13:303, 1928
12. Shulman NR, Reid DM: Platelet immunology, in Colman RW, Hirs J, Mader VJ, Salzman EW (eds): Hemostasis and Thrombosis (ed 3). Philadelphia, PA, Lippincott, 1994, p 414
13. Aster RH, George JN: Thrombocytopenia due to enhanced platelet destruction by immunological mechanism, in Williams WJ, Buetle E, Erslev AJ, Lichtman MA (eds): Hematology. New York, NY, McGraw-Hill, 1990, p 1370
14. Christie DJ, Sauro SC, Cavanaugh AL, Kaplan ME: Severe thrombocytopenia in an acquired immunodeficiency syndrome patient associated with pentamidine-dependent antibodies specific for glycoprotein IIb/IIIa. Blood 82:3075, 1993
15. Curtis BR, McFarland JG, Wu G-G, Visentin GP, Aster RH: Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on glycoprotein IIb/IIIa complex. Blood 84:176, 1994
16. Kunicki TJ, Russell N, Nurden AT, Aster RH, Caen JP: Further studies of platelet receptor for quinine-and quinidine-dependent antibodies. J Immunol 126:398, 1981
17. Berndt MD, Chong BH, Bull HA, Zola H, Castaldi PA: Molecular characterization of quinine/quinidine drug-dependent antibody platelet interaction using monoclonal antibodies. Blood 66:1292, 1985
18. Christie DJ, Mullen PC, Aster RH: Quinine-and quinidine platelet antibodies can react with GP IIb/IIIa. Br J Haematol 67:213, 1987
19. Pfueller SL, Bilston RA, Logan D, Gibson JM, Firkin BG: Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine-and quinidine-induced thrombocytopenia: Involvement of glycoproteins Ib, IIb, IIIa and IX. Blood 72:1155, 1988
20. Visentin GP, Newman PJ, Aster RH: Characteristics of quinine-and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood 77:2668, 1991
21. Mueller-Eckhardt C, Kiefel V: Laboratory methods for detection of platelet antibodies and identification of antigens, in Kunicki TJ, George JN (eds): Platelet Immunology, Molecular and Clinical Aspects. Philadelphia, PA, Lippincott, 1989, p 436
22. McMillan R: Antigen-specific assays in immune thrombocytopenia. Trans Med Rev 4:136, 1990
23. Stockelberg D, Hou M, Jacobsson S, Kutti J, Wadenvik H: Detection of platelet antibodies in chronic idiopathic thrombocytopenia purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA. Eur J Haematol 56:72, 1996
24. Askew BC, Bednar RA, Bednar B, Claremon DA, Cook JJ, McIntyre CJ, Hunt CA, Gould RJ, Lynch RJ, Lynch JJ, Gaul SL, Stranieri MT, Sitko GR, Holahan MA, Glass JD, Hamill T, Gorham LM, Prueksaritanont T, Baldwin JJ, Hartman GD: Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists. J Med Chem 40:1779, 1997
25. Cook JJ, Sitko GR, Holaha MA, Stranieri MT, Glass JD, Askew BC, McIntyre CJ, Claremon DA, Baldwin JJ, Hartman GD, Gould RJ, Lynch JJ Jr: Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of (A1-L), a long-acting GP IIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. J Pharmacol Exp Ther 281:677, 1997
26. Egbertson MS, Cook JJ, Bednar B, Prugh JD, Bednar RA, Gould RJ, Hartman GD, Homnick C, Lynch Jr. JJ, Libby LA, Lynch RJ, Holahan M, Stranieri MT, Vassallo LM, Young SD: Non-peptide GP IIb/IIIa inhibitors. Centrallyconstrained thienothiophene alpha-sulfonamides are potent in vivo inhibitors of platelet aggregation. J Med Chem 42:1572, 1999
27. Hutchinson JH, Cook JJ, Brashear KM, Breslin MJ, Glass JD, Gould RJ, Halczenko W, Holahan MA, Lynch RJ, Sitko GR, Stranieri MT, Hartman GD: Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1(1H)-isoquinolinone-based antagonists and ethyl ester prodrugs. J Med Chem 39:4583, 1996
28. Duggan ME, Naylor-Olsen AM, Perkins JJ, Anderson PS, Chang CT-C, Cook JJ, Gould RJ, Ihle NC, Hartman GD, Lynch JJ, Lynch RJ, Manno PD, Schaffer LW, Smith RL: Nonpeptide fibrinogen receptor antagonists. 7. Design and synthesis of the potent, orally active fibrinogen receptor antagonist L-734,217. J Med Chem 38:3332, 1995
29. Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA, Hartman GD, Gould RJ, Bednar B: Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. J Pharmacol Exp Ther 2285:1317, 1998
30. Cook JJ, Holahan MA, Lyle EA, Ramjit DR, Sitko GR, Stranieri MT, Stupienski RF, Wallace AA, Hand EL, Gehret JR, Kothstein T, Drag MD, McCormick GY, Perkins JJ, Ihle NC, Duggan ME, Hartman GD, Gould RJ, Lynch JJ Jr: Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217. J Pharmacol Exp Ther 278:62, 1996
31. Egbertson MS, Bednar B, Bednar RA, Hartman GD, Gould RJ, Lynch RJ, Vassallo LM, Young SD: Nonpeptide glycoprotein IIb/IIIa inhibitors. 9. Centrally constrained alpha-sulfonamides are useful tools for exploring platelet function. Bioorg Med Chem Lett 6:1415, 1996
32. Bednar B, Cunningham ME, McQueney PA, Egbertson MS, Askew BC, Bednar RA, Hartman GD, Gould RJ: Flow cytometric measurement of kinetic and equilibrium binding parameters of Arginine-glycine-aspartic acid ligands in binding to glycoprotein IIIb/IIIa on platelets. Cytometry 28:58, 1997
33. Shattil SJ, Brass LF, Bennett JS, Pandhi P: Biochemical and functional consequences of dissociation of platelet membrane glycoprotein IIb/IIIa complex. Blood 66:92, 1985
34. Calvete JJ: Clues for understanding the structure and function of a prototypic human integrin: The platelet clycoprotein IIb/IIIa complex. Thromb Haemost 72:1, 1994
35. 3 in human embryonic kidney 293 cells. Mol Pharmacol 52:227, 1997
36. Hosono M, Sone N, Endo K, Saga T, Kobayashi H, Hosono M, Sakahara H, Yasunaga K, Konoshi J: Kinetics of platelets in dogs with thrombocytopenia induced by antiglycoprotein IIb/IIIa receptor monoclonal antibody. Nucl Med Biol 22:71, 1995
37. Bednar B, Bednar RA, Cook JJ, Bollag DM, Chang CT, Gaul SL, McQueney PA, Egbertson MS, Hartman GD, Holahan MA, Lynch JJ, Gould RJ: Drug-dependent antibodies against GP IIb/IIIa induce thrombocytopenia. Circulation 94:1-99, 1996 (abstr)
38. Christie DJ, Weber RW, Muller PC, Koch JM, Aster RH: Structural features of quinidine and quinine molecules necessary for binding of drug-induced antibody to human platelets. J Lab Clin Med 104:730, 1984
39. Bizzao N: EDTA-dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 50:103, 1995